Erin Schenk

14PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Sonam Puri, Natasha B Leighl, Nofisat Ismaila

|Feb 27, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3.

Natasha B Leighl, Nofisat Ismaila, Greg Durm

|Jul 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.

Collin M Blakely, Anatoly Urisman, Matthew A Gubens

|Apr 08, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights.

Dwight H Owen, Ishmael A Jaiyesimi, Natasha B Leighl

Pageof 3

Frequent Collaborators

9 joint publications

Nofisat Ismaila

9 joint publications

Natasha B Leighl

8 joint publications

Narjust Florez

8 joint publications

Navneet Singh